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Objectives: The objective of the study was to investigate the impact of no-reflow phenomenon on five-year mortality in patients with ST-segment 
elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PCI). This impact was also assessed in relation with 
infarct size. 
Background: The impact of no-reflow on long-term mortality in patients with STEMI has been insufficiently studied.
Methods: This study included 1406 patients with STEMI treated by primary PCI. No-reflow was diagnosed using angiographic criteria. Infarct size 
was measured with single photon emission computed tomography (SPECT) imaging 7-14 days after the acute event. The primary outcome was five-
year mortality.
Results: No-reflow phenomenon was diagnosed in 410 patients (29%). Infarct size was 15.0% [6.0%-29.0%] of the left ventricle in the no-reflow 
group versus 8.0% [2.0-21.0%] of the left ventricle in the reflow group (p<0.001). There were 132 deaths during follow-up (9.4%). Of them, 59 
deaths occured among patients with no-reflow and 73 deaths occured among patients with reflow (Kaplan-Meier estimates of five-year mortality 
18.2% and 9.5%, respectively, odds ratio [OR] 2.02; 95% confidence interval, 1.44-2.82; p<0.001). The Cox proportional hazards model adjusting 
for infarct size among other variables identified the no-reflow phenomenon as an independent correlate of five-year mortality (hazards ratio [HR] 
1.63; 95% CI, 1.08-2.46; p=0.019).
Conclusions: In patients with STEMI treated by primary PCI, no-reflow phenomenon is a strong predictor of five-year mortality. No-reflow 
phenomenon after PCI provides prognostic information that is independent of and beyond that provided by infarct size.
